Zkušenosti pracoviště s erlotinibem (Tarcevou) u nemocných s nemalobuněčným karcinomem plic (NSCLC)

Warning

This publication doesn't include Faculty of Sports Studies. It includes Faculty of Medicine. Official publication website can be found on muni.cz.

Title in English	The experience of the clinical center with erlotinib (Tarceva) in patients with non-small cell lung cancer (NSCLC)
Authors	TOMÍŠKOVÁ Marcela SKŘIČKOVÁ Jana KAPLANOVÁ Jana BABIČKOVÁ Lenka VAŠUTOVÁ Irena KADLEC Bohdan TURČÁNI Pavel STAŇKOVÁ Yvonne NEBESKÝ Tomáš SVOBODNÍK Adam
Year of publication	2007
Type	Article in Proceedings
Conference	XV. Západočesképneumoonkologické dny - Plzeň
MU Faculty or unit	Faculty of Medicine
Citation
Field	Pneumology
Keywords	erlotinib; non-small cell lung cancer
Description	The wealth of experience the Brno Department of Pulmonary Diseases has amassed over the time treating non-small cell lung cancer with erlotinib (Tarceva)is outstanding in the Czech Republic; in order to share this experience the authors presented their results in this paper.
Related projects:	Environment - carcinogenesis - oncology